In a patient with hyperdynamic left ventricular wall motion and diastolic fluttering of the anterior mitral leaflet, what is the likely etiology and what steps should be taken to evaluate and manage this finding?

Hyperdynamic Wall Motion with Diastolic Fluttering of Anterior Mitral Leaflet

The combination of hyperdynamic left ventricular wall motion and diastolic fluttering of the anterior mitral leaflet most likely indicates left ventricular outflow tract (LVOT) obstruction, typically from hypertrophic cardiomyopathy (HCM), though it can occur in structurally normal hearts under hyperdynamic conditions with volume depletion or catecholamine excess.

Most Likely Etiology

The clinical presentation suggests dynamic LVOT obstruction with systolic anterior motion (SAM) of the mitral valve 1. In HCM, approximately 75% of patients develop LVOT obstruction through two mechanisms: septal hypertrophy narrowing the outflow tract, and anatomic mitral valve alterations (longer leaflets, anteriorly displaced papillary muscles) that make the valve susceptible to abnormal flow vectors 1.

Alternative Etiologies to Consider:

• Hyperdynamic states without structural disease: Volume depletion combined with catecholamine therapy, anemia, or severe hypovolemia can cause SAM even in structurally normal hearts 2, 3, 4
• Left atrial myxoma: Can cause diastolic fluttering from turbulent flow around the tumor prolapsing between mitral leaflets 5
• Post-cardiac surgery states: Particularly with anemia and hyperdynamic LV function 3

Diagnostic Evaluation Algorithm

Immediate Echocardiographic Assessment

Perform comprehensive transthoracic echocardiography (TTE) with specific focus on 1, 6, 7:

1. Measure maximal wall thickness - particularly basal septum (≥15 mm suggests HCM in adults)
2. Assess LVOT gradient at rest - peak gradient ≥30 mmHg indicates obstruction, ≥50 mmHg is threshold for considering advanced therapies
3. Document SAM presence and timing - mid-to-late systolic SAM with posteriorly directed mitral regurgitation is classic for HCM
4. Evaluate mitral valve morphology - look for elongated leaflets, papillary muscle displacement, abnormal chordal attachments 8, 9
5. Measure LV cavity size and systolic function - small hyperdynamic cavity suggests obstruction

Provocative Maneuvers

If resting gradient <50 mmHg, perform provocative testing 1, 6:

• Standing from squatting position
• Valsalva strain maneuver
• Exercise echocardiography (preferred over dobutamine, which lacks specificity) 1

These maneuvers decrease preload and increase contractility, unmasking latent obstruction.

Additional Imaging

Cardiac MRI with late gadolinium enhancement if echocardiography is suboptimal or to:

• Quantify fibrosis and scarring
• Assess for apical aneurysm
• Exclude phenocopies 1

Exclude Reversible Causes

Check for hyperdynamic precipitants 2, 3, 4:

• Volume status (hypovolemia)
• Hemoglobin (anemia)
• Catecholamine/inotrope use
• Blood pressure (hypotension)
• Thyroid function

Management Strategy

If HCM with LVOT Obstruction is Confirmed:

For symptomatic patients with gradient ≥50 mmHg 1, 6:

1. First-line medical therapy:

   • Beta-blockers (avoid vasodilators, diuretics, positive inotropes)
   • Consider disopyramide if beta-blockers insufficient
   • Mavacamten (cardiac myosin inhibitor) - achieves mean gradient reduction of 37.2 mmHg, with 86% of patients improving to NYHA class I-II 10

2. Septal reduction therapy if drug-refractory:

   • Surgical septal myectomy is gold standard with superior long-term outcomes 10, 11
   • Intraoperative TEE mandatory to assess mitral valve and adequacy of myectomy 7
   • Alcohol septal ablation alternative but higher risk of conduction abnormalities and re-intervention 10

If Non-HCM Hyperdynamic State:

Immediately address precipitating factors 2, 3, 4:

• Withdraw catecholamines/inotropes
• Volume resuscitation for hypovolemia
• Correct anemia with transfusion if severe
• Beta-blockade to reduce hypercontractility

Critical Pitfall to Avoid:

Do not administer diuretics, vasodilators, or positive inotropes - these worsen LVOT obstruction by decreasing preload or increasing contractility 1, 2. This is a common error that can precipitate hemodynamic collapse.

Family Screening

If HCM is diagnosed, screen first-degree relatives 7:

• TTE every 1-2 years in children/adolescents
• TTE every 3-5 years in adults
• Genetic testing for pathogenic variants

The dynamic nature of LVOT obstruction means gradients vary with daily activities, food, alcohol, and even respiration 1. Serial imaging and clinical correlation are essential for optimal management decisions.